Cheryl Maurice, MD
Internal Medicine · Chandler, AZNPI 1265497713
Payments from drug & device makers
Across 3 payments — averaging $60.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$145
- Nevro Corp.$22
- Bardy Diagnostics, Inc.$15
What the payments were for
- Food & beverage$182100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1 | $145 |
| Nevro Corp. | 1 | $22 |
| Bardy Diagnostics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$145
How this compares
$182 in reported general payments places this provider in the 50th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 30 | $42,292 |
| MounjaroTirzepatide | 19 | $25,118 |
| EliquisApixaban | 14 | $20,113 |
| MyrbetriqMirabegron | 19 | $17,018 |
| JanuviaSitagliptin Phosphate | 12 | $15,176 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $12,067 |
| PremarinEstrogens, Conjugated | 12 | $6,803 |
| Levothyroxine Sodium | 365 | $3,928 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $3,769 |
| Pantoprazole Sodium | 204 | $3,475 |
| Atorvastatin Calcium | 413 | $3,318 |
| Bupropion XlBupropion Hcl | 70 | $2,363 |
| SynthroidLevothyroxine Sodium | 45 | $2,342 |
| Losartan Potassium | 243 | $2,212 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 20 | $1,879 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Chandler
- Janelle WeyerChandler$5.5M
- Randall SeveranceChandler$3.1M
- Punal PatelChandler$604K
- Yessica SachdevaMesa$13.7M
- Louise TaberPhoenix$8.5M
- Robert MutterperlTucson$5.3M
- Jalal AbbasSun City West$4.8M
- Nebojsa SkrepnikTucson$4.7M
- Philip MathewTempe$4.1M
- Justin MoserScottsdale$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.